691 related articles for article (PubMed ID: 32353039)
1. Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of population-based observational studies.
Jarvis H; Craig D; Barker R; Spiers G; Stow D; Anstee QM; Hanratty B
PLoS Med; 2020 Apr; 17(4):e1003100. PubMed ID: 32353039
[TBL] [Abstract][Full Text] [Related]
2. Lean non-alcoholic fatty liver disease and associated metabolic disturbance: A Saudi Arabian cross-sectional study.
Khayyat YM
Physiol Rep; 2021 Jul; 9(14):e14949. PubMed ID: 34278728
[TBL] [Abstract][Full Text] [Related]
3. Comparison of all-cause mortality associated with non-alcoholic fatty liver disease and metabolic dysfunction-associated fatty liver disease in Taiwan MJ cohort.
Cheng WC; Chen HF; Cheng HC; Li CY
Epidemiol Health; 2024; 46():e2024024. PubMed ID: 38317531
[TBL] [Abstract][Full Text] [Related]
4. Global incidence of adverse clinical events in non-alcoholic fatty liver disease: A systematic review and meta-analysis.
Le MH; Le DM; Baez TC; Dang H; Nguyen VH; Lee K; Stave CD; Ito T; Wu Y; Yeo YH; Ji F; Cheung R; Nguyen MH
Clin Mol Hepatol; 2024 Apr; 30(2):235-246. PubMed ID: 38281814
[TBL] [Abstract][Full Text] [Related]
5. Lean non-alcoholic fatty liver disease and the risk of all-cause mortality: An updated meta-analysis.
Wongtrakul W; Charatcharoenwitthaya N; Charatcharoenwitthaya P
Ann Hepatol; 2024; 29(3):101288. PubMed ID: 38278181
[TBL] [Abstract][Full Text] [Related]
6. Gastrointestinal cancers in lean individuals with non-alcoholic fatty liver disease: A systematic review and meta-analysis.
Souza M; Diaz I; Barchetta I; Mantovani A
Liver Int; 2024 Jan; 44(1):6-14. PubMed ID: 37833849
[TBL] [Abstract][Full Text] [Related]
7. Disease State Transition Probabilities Across the Spectrum of NAFLD: A Systematic Review and Meta-Analysis of Paired Biopsy or Imaging Studies.
Le P; Payne JY; Zhang L; Deshpande A; Rothberg MB; Alkhouri N; Herman W; Hernandez AV; Schleicher M; Ye W; Dasarathy S
Clin Gastroenterol Hepatol; 2023 May; 21(5):1154-1168. PubMed ID: 35933075
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of non-alcoholic fatty liver disease differences from metabolic dysfunction-associated fatty liver disease based on clinical features].
Liu YX; Guo F; Niu LN; Zhang B; Dou J; Xu Q; Ning ZH; Wang XZ
Zhonghua Gan Zang Bing Za Zhi; 2024 Apr; 32(4):346-353. PubMed ID: 38733190
[No Abstract] [Full Text] [Related]
9. Non-invasive tools for liver steatosis and steatohepatitis predict incidence of diabetes, cardiovascular disease and mortality 20 years later: The ATTICA cohort study (2002-2022).
Kouvari M; Chrysohoou C; Damigou E; Barkas F; Kravvariti E; Liberopoulos E; Tsioufis C; Sfikakis PP; Pitsavos C; Panagiotakos D; Mantzoros CS;
Clin Nutr; 2024 Mar; 43(3):900-908. PubMed ID: 38387279
[TBL] [Abstract][Full Text] [Related]
10. Risk factors of hepatocellular carcinoma in non-alcoholic fatty liver disease: a systematic review and meta-analysis.
Guo WP; Zhang HY; Liu LX
Eur Rev Med Pharmacol Sci; 2023 Dec; 27(24):11890-11903. PubMed ID: 38164853
[TBL] [Abstract][Full Text] [Related]
11. Anti-osteoporotic treatments in the era of non-alcoholic fatty liver disease: friend or foe.
Chondrogianni ME; Kyrou I; Androutsakos T; Flessa CM; Menenakos E; Chatha KK; Aranan Y; Papavassiliou AG; Kassi E; Randeva HS
Front Endocrinol (Lausanne); 2024; 15():1344376. PubMed ID: 38524631
[TBL] [Abstract][Full Text] [Related]
12. Non-alcoholic fatty liver disease and coexisting depression, anxiety and/or stress in adults: a systematic review and meta-analysis.
Shea S; Lionis C; Kite C; Lagojda L; Uthman OA; Dallaway A; Atkinson L; Chaggar SS; Randeva HS; Kyrou I
Front Endocrinol (Lausanne); 2024; 15():1357664. PubMed ID: 38689730
[TBL] [Abstract][Full Text] [Related]
13. Regional variation in NAFLD prevalence and risk factors among people living with HIV in Europe: a meta-analysis.
Jin D; Jin S; Zhou T; Cui Z; Guo B; Li G; Zhang C
Front Public Health; 2023; 11():1295165. PubMed ID: 38259755
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic accuracy of AGILE 3+ score for advanced fibrosis in patients with NAFLD: A systematic review and meta-analysis.
Dalbeni A; Lombardi R; Henrique M; Zoncapè M; Pennisi G; Petta S; Tateishi R; Keklikkiran C; Colecchia A; Sacerdoti D; Mantovani A; Ravaioli F
Hepatology; 2024 May; 79(5):1107-1116. PubMed ID: 37976417
[TBL] [Abstract][Full Text] [Related]
15. Hepatic, Extra-hepatic Outcomes and Causes of Mortality in NAFLD - An Umbrella Overview of Systematic Review of Meta-Analysis.
Xiao J; Ng CH; Chan KE; Fu C; Tay P; Yong JN; Lim WH; Tan DJH; Syn N; Wong ZY; Tseng M; Chew N; Huang DQ; Dan YY; Wong VW; Loomba R; Siddiqui MS; Sanyal AJ; Noureddin M; Muthiah MD
J Clin Exp Hepatol; 2023; 13(4):656-665. PubMed ID: 37440949
[TBL] [Abstract][Full Text] [Related]
16. Non-alcoholic fatty liver disease.
Li W; Alazawi W
Clin Med (Lond); 2020 Sep; 20(5):509-512. PubMed ID: 32934047
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and risk of nonalcoholic fatty liver disease among adult psoriatic patients: A systematic review, meta-analysis, and trial sequential analysis.
Hu J; Shao Y; Gui C; Xiao Y; Li L; Li Z
Medicine (Baltimore); 2024 May; 103(18):e38007. PubMed ID: 38701269
[TBL] [Abstract][Full Text] [Related]
18. Gestational diabetes mellitus and development of intergenerational non-alcoholic fatty liver disease (NAFLD) after delivery: a systematic review and meta-analysis.
Foo RX; Ma JJ; Du R; Goh GBB; Chong YS; Zhang C; Li LJ
EClinicalMedicine; 2024 Jun; 72():102609. PubMed ID: 38707911
[TBL] [Abstract][Full Text] [Related]
19. Advanced Glycation End-Products in Common Non-Infectious Liver Diseases: Systematic Review and Meta-Analysis.
Litwinowicz K; Waszczuk E; Gamian A
Nutrients; 2021 Sep; 13(10):. PubMed ID: 34684371
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of portal vein thrombosis in non-alcoholic fatty liver disease: a meta-analysis of observational studies.
Stupia R; Lombardi R; Cattazzo F; Zoncapè M; Mantovani A; De Marco L; Mantovani A; Fracanzani AL; Sacerdoti D; Dalbeni A
J Thromb Thrombolysis; 2024 Feb; 57(2):330-336. PubMed ID: 38066387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
